US Patent Issued to GlaxosmithKline Biologicals on Sept. 9 for "Cycloalkyne derivatized saccharides" (Italian, American Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,409,231, issued on Sept. 9, was assigned to GlaxosmithKline Biologicals SA (Rixensart, Belgium).

"Cycloalkyne derivatized saccharides" was invented by Roberto Adamo (Siena, Italy), Francesco Berti (Siena, Italy) and Qi-Ying Hu (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure provides novel saccharide derivatives, conjugates, and methods for making the derivatives and conjugates."

The patent was filed on May 14, 2021, under Application No. 17/320,482.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fse...